Angers, France

University of Angers

www.univ-angers.fr
Angers, France

The University of Angers is an institution of higher learning situated in the town of the same name, in western France. It was founded in 1356, closed down in 1793, and reestablished in 1971.The pre-revolutionary institution is sometimes looked upon as the precedent institution of the Catholic University of the West, though, as both popes and kings have granted charters to the old University of Angers, it is not a clear predecessor to either of the current Universities in Angers. Wikipedia.

SEARCH FILTERS
Time filter
Source Type

Patent
University of Angers | Date: 2017-07-26

The present invention relates to a method for displaying an easy-to-understand medical image, comprising the steps of: a. obtaining a medical image, b. identifying at least one feature on the image of step (a), c. generating at least one mask highlighting the at least one feature, d. displaying at least one easy-to-understand medical image including at least one mask on which the at least one feature identified in step (b) is highlighted.


Patent
University of Angers | Date: 2015-04-08

An in vitro prognostic method for assessing the risk of death or of liver-related event in a subject, includes: a) obtaining at least one, preferably 2, of the following variables from the subject: i. biomarkers measured in a sample from the subject; ii. clinical data; iii. binary markers; iv. blood test results; b) optionally obtaining at least one blood test result by univariate combination, preferably with a binary logistic regression, of the at least one variable obtained in step a), the blood test not being a Fibrotest, c) obtaining at least one physical data from medical imaging or clinical measurement, from elastometry, or Vibration Controlled Transient Elastography, and d) mathematically combining in a multivariate time-dependent model the variable obtained in step a) and/or the at least one blood test result obtained in step b); and the at least one physical data, obtained in step c) thereby obtaining a prognostic score.


Patent
University of Angers | Date: 2015-12-04

Insecticide composition where the active ingredient includes a combination of at least one synthetic insecticidal molecule from the neonicotinod family, and at least one synergistic agent, which is chosen among the insect repellent agents and present in the composition at a molar ratio of the synergistic agent to the synthetic insecticidal molecule in the composition comprised between 0.001 and 0.2. The insecticide includes a synergistic combination of DEET or IR3535 with thiaclopride or thiamethoxam that are more effective at low doses.


Patent
University of Angers, French Institute of Health and Medical Research | Date: 2015-06-23

The present invention shows that the isolated NFL-TBS_(40-63 )peptide is highly specific for neural stem cells. It is therefore presented here for use in a method for detecting these cells in vitro or in vivo, for addressing chemical compounds or biological materials to said cells, or for treating neurodegenerative disorders or brain tumours.


Patent
French Institute of Health, Medical Research, University of Nantes, University of Angers, French National Center for Scientific Research and Institute Of Cancerologie Of Louest Site Rene Gauducheau | Date: 2015-05-22

Disclosed are methods for determining whether a patient will achieve a response after radiation therapy, in particular a method for determining whether a patient suffering from a cancer will achieve a response after radiation therapy including the steps of i) determining the level of ceramide in a first blood sample obtained from the patient before radiation therapy, ii) determining the level of ceramide in a second blood sample obtained from the patient during or just after radiation therapy, iii) comparing the level determined at step i) with the level determined at step ii) and iv) concluding that the patient will achieve response when the level determined at step ii) is higher than the level determined at step i) or concluding that the patient will not achieve a response when the level determined at step ii) is lower than the level determined at step i).


Patent
University of Angers | Date: 2017-02-15

The present invention relates to in vitro prognostic method for assessing the risk of death or of liver-related event in a subject, comprising: a. obtaining at least one, preferably at least 2, of the following variables from the subject: i. biomarkers measured in a sample from the subject; ii. clinical data; iii. binary markers; iv. blood test results; b. optionally obtaining at least one blood test result by univariate combination, preferably with a binary logistic regression, of the at least one variable obtained in step (a), said blood test not being a Fibrotest, c. obtaining at least one physical data from medical imaging or clinical measurement, preferably from elastometry, more preferably from Vibration Controlled Transient Elastography (VCTE), and d. mathematically combining in a multivariate time-dependent model said at least one variable obtained in step (a) and/or said at least one blood test result obtained in step b); and said at least one physical data, obtained in step (c) thereby obtaining a prognostic score.


Insecticide composition wherein the active ingredient comprises the combination of a neonicotinoid insecticide, thiamethoxam as synthetic insecticide molecule, and at least one synergistic agent, which is chosen among the insect repellent agents and present at a molar ratio of said synergistic agent to thiamethoxam comprised between 0.001 and 0.2 in the composition. Synergistic effect is observed at low doses. Use of the insecticide composition wherein said composition is sprayed or deposited on, or impregnated to a support, such as net, fabrics, cloth or tent, in the fight against insects which are harmful to human, to animals and/or to crops, and in particular against pyrethroid resistant mosquitoes.


Patent
University of Angers | Date: 2016-12-02

This invention relates to method of diagnosing the presence and/or severity of a liver pathology and/or of monitoring the effectiveness of a curative treatment against a liver pathology in an individual, leading to a score, comprising the combination, of at least one marker from a blood test and of at least one data issued from a physical method of diagnosing liver fibrosis, said physical method being further defined as elastometry, said combination being performed through a mathematical function.


Patent
French Institute of Health, Medical Research, Montpellier University, Assistance Publique Hopitaux De Paris, University Paris Est Creteil and University of Angers | Date: 2016-10-17

The present invention relates to methods and pharmaceutical compositions for cardioprotection of subjects who experienced a myocardial infarction. In particular, the present invention relates to a ligand of the sonic hedgehog signaling pathway for use in the cardioprotection of a subject who experienced a myocardial infarction.


Patent
University of Angers | Date: 2017-06-07

The invention relates to a method for determining a perfusion speed in a medical device assisting in the administration of a substance as a function of a physiological parameter and to a device capable of implementing the method, and also to a computer program product for implementing the method.

Loading University of Angers collaborators
Loading University of Angers collaborators